Clinical Trial Update: A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing Aticaprant plus an antidepressant to prevent relapse of depressive symptoms in adults with major depressive disorder and anhedonia has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Aticaprant (Aticaprant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major, Anhedonia | Phase 3 | Status: TERMINATED